encapsulated scFv-beta 1-expressing cells (Novartis)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug Nameencapsulated scFv-beta 1-expressing cells (Novartis)

Drug Alias NameN/A

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibodyBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody fragmentCell and gene therapy > Cell therapy

Mechanisms of ActionBeta amyloid A4 protein modulators

TargetsBeta amyloid A4 protein

Therapy Area/IndicationsAlzheimer Disease

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesNovartis Institutes For Biomedical Research Inc

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesNovartis Institutes For Biomedical Research Inc

Active IndicationsN/A

Inactive IndicationsAlzheimer Disease

Other Information

ATC CodeN/A